Cargando…

Thalassemia and Hemoglobin E in Southern Thai Blood Donors

Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuinoon, Manit, Kruachan, Kwanta, Sengking, Warachaya, Horpet, Dararat, Sungyuan, Ubol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094851/
https://www.ncbi.nlm.nih.gov/pubmed/25050123
http://dx.doi.org/10.1155/2014/932306
_version_ 1782325906586468352
author Nuinoon, Manit
Kruachan, Kwanta
Sengking, Warachaya
Horpet, Dararat
Sungyuan, Ubol
author_facet Nuinoon, Manit
Kruachan, Kwanta
Sengking, Warachaya
Horpet, Dararat
Sungyuan, Ubol
author_sort Nuinoon, Manit
collection PubMed
description Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining the frequency of α-thalassemia 1 trait, β-thalassemia trait, and Hb E-related syndromes in Southern Thai blood donors. One hundred and sixteen voluntary blood donors, Southern Thailand origin, were recruited for thalassemia and Hb E screening by red blood cell indices/dichlorophenolindophenol precipitation test. β-Thalassemia and Hb E were then identified by high performance liquid chromatography and 4 common α-thalassemia deletions were characterized by a single tube-multiplex gap-polymerase chain reaction. Overall frequency of hemoglobinopathies was 12.9%, classified as follows: homozygous α-thalassemia 2 (1.7%), heterozygous α-thalassemia 1 (1.7%), heterozygous β-thalassemia without α-thalassemia (0.9%), heterozygous Hb E without α-thalassemia (5.2%), double heterozygotes for Hb E/α-thalassemia 1 (1.7%), homozygous Hb E without α-thalassemia (0.9%), and homozygous Hb E with heterozygous α-thalassemia 2 (0.9%). The usefulness of thalassemia screening is not only for receiving highly effective red blood cells in the recipients but also for encouraging the control and prevention program of thalassemia in blood donors.
format Online
Article
Text
id pubmed-4094851
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40948512014-07-21 Thalassemia and Hemoglobin E in Southern Thai Blood Donors Nuinoon, Manit Kruachan, Kwanta Sengking, Warachaya Horpet, Dararat Sungyuan, Ubol Adv Hematol Research Article Thalassemia and hemoglobin E (Hb E) are common in Thailand. Individuals with thalassemia trait usually have a normal hemoglobin concentration or mild anemia. Therefore, thalassemic individuals who have minimum acceptable Hb level may be accepted as blood donors. This study was aimed at determining the frequency of α-thalassemia 1 trait, β-thalassemia trait, and Hb E-related syndromes in Southern Thai blood donors. One hundred and sixteen voluntary blood donors, Southern Thailand origin, were recruited for thalassemia and Hb E screening by red blood cell indices/dichlorophenolindophenol precipitation test. β-Thalassemia and Hb E were then identified by high performance liquid chromatography and 4 common α-thalassemia deletions were characterized by a single tube-multiplex gap-polymerase chain reaction. Overall frequency of hemoglobinopathies was 12.9%, classified as follows: homozygous α-thalassemia 2 (1.7%), heterozygous α-thalassemia 1 (1.7%), heterozygous β-thalassemia without α-thalassemia (0.9%), heterozygous Hb E without α-thalassemia (5.2%), double heterozygotes for Hb E/α-thalassemia 1 (1.7%), homozygous Hb E without α-thalassemia (0.9%), and homozygous Hb E with heterozygous α-thalassemia 2 (0.9%). The usefulness of thalassemia screening is not only for receiving highly effective red blood cells in the recipients but also for encouraging the control and prevention program of thalassemia in blood donors. Hindawi Publishing Corporation 2014 2014-06-23 /pmc/articles/PMC4094851/ /pubmed/25050123 http://dx.doi.org/10.1155/2014/932306 Text en Copyright © 2014 Manit Nuinoon et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nuinoon, Manit
Kruachan, Kwanta
Sengking, Warachaya
Horpet, Dararat
Sungyuan, Ubol
Thalassemia and Hemoglobin E in Southern Thai Blood Donors
title Thalassemia and Hemoglobin E in Southern Thai Blood Donors
title_full Thalassemia and Hemoglobin E in Southern Thai Blood Donors
title_fullStr Thalassemia and Hemoglobin E in Southern Thai Blood Donors
title_full_unstemmed Thalassemia and Hemoglobin E in Southern Thai Blood Donors
title_short Thalassemia and Hemoglobin E in Southern Thai Blood Donors
title_sort thalassemia and hemoglobin e in southern thai blood donors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094851/
https://www.ncbi.nlm.nih.gov/pubmed/25050123
http://dx.doi.org/10.1155/2014/932306
work_keys_str_mv AT nuinoonmanit thalassemiaandhemoglobineinsouthernthaiblooddonors
AT kruachankwanta thalassemiaandhemoglobineinsouthernthaiblooddonors
AT sengkingwarachaya thalassemiaandhemoglobineinsouthernthaiblooddonors
AT horpetdararat thalassemiaandhemoglobineinsouthernthaiblooddonors
AT sungyuanubol thalassemiaandhemoglobineinsouthernthaiblooddonors